Congratulations to Yumin @yuminimin on our study in @SciImmunology! Anti-CTLA-4 drives TFH–B cell responses and tumor-reactive IgG1 antibodies, enabling macrophage-mediated GBM clearance. Proud of this work! https://t.co/hwoSfcHyxz
Gut dysbiosis from high-salt diet promotes #glioma via propionate-mediated TGF-β activation. From Chae Won Kim (@EmmaChaewonKim), Hyun-Jin Kim, @heungkyulee, and colleagues 👉 https://t.co/CU19dQ2VSK
📘 Part of 2025: The Year in Experimental Medicine https://t.co/lfplvI5z52
🎥 New video summary of a study by Chae Won Kim (@EmmaChaewonKim), Hyun-Jin Kim, Heung Kyu Lee (@heungkyulee) & colleagues (https://t.co/tjzLXwZMuG ) showing that gut dysbiosis from high-salt diet promotes glioma via propionate-mediated TGF-β activation: https://t.co/ogU1osm9zV
Our new study led by Hyeon Cheol shows gut microbiota dysbiosis induced by brain tumors modulates the efficacy of Immunotherapy : #microbiota#glioblastoma#Tcells#immunotherapy Cell Reports https://t.co/RvWFBWPmdD
A high-salt diet increases Bacteroides abundance & intestinal propionate, activating the HIF-1α–TGF-β1 axis & promoting glioma invasion. Kim et al reveal insights into how gut microbiota & their metabolites contribute to glioma development & progression https://t.co/aHtWYBAdVI
🚨 Just out from our lab in JEM!
Led by @EmmaChaewonKim & Hyun-Jin Kim, this study reveals how a high-salt diet reshapes gut microbiota to drive glioma via propionate-mediated TGF-β.
👉 https://t.co/S88ZovHFef
#glioma#microbiome#Highsaltdiet
🎉 Huge congratulations to @janghyun_park_ , who earned his PhD from #KAIST and has now been awarded the prestigious ChadTough Defeat DIPG Foundation fellowship mentored by @jonykipnis ! 🧠💪 Wishing you great success in this important journey! 🚀
I’m excited to share that my paper, 'Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness, increasing anti-PD-1 therapy responsiveness against glioblastoma,' is now published online! #JITC#glioblastoma#tumorimmunology#cancerimmunotherapy Read https://t.co/kuo5xMoXy2
I'm thrilled to share that Dr. Ku, Keun Bon from our lab started his PhD in his late 30s and has overcome many challenges. He identified the mechanism of FcgRIIB in CD8 T cells resistant to ICB therapy for brain tumors, and his work is now published in https://t.co/IuUmG8VNSD
@Joshilabyale Nik, I think your journey as a scientist began at AAI2006 in Boston. I've attached a few photos of your poster @Tcellogic@Joshilabyale enjoy the memories!
Accepting the 2024 Jessie Stevenson Kovalenko Medal is #NASmember Ruslan Medzhitov of @YaleMed and @HHMINEWS for foundational contributions to the understanding of innate immunity. #medicine#immunology#NAS161#NASaward
Watch live: https://t.co/U6h0ZAis4Y